TVRD

AS OF

Dec 12 closing price

Price

$4.41

Change

-$0.08 (-1.78%)

Capitalization

41.37M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

TVRD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Tvardi Therapeutics (TVRD) Ownership - Who owns Tvardi Therapeutics?

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

TVRD

Capitalization

41.4M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

36.5M

Total Cash/Share

3.89

Total Debt

228K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

27.9M

P/B Ratio

1.48

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

3.48

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

N/A

Shares Held By Institutions

110M

Shares Outstanding - Current

9.38M

Total Liabilities

11.2M

Total Volume MTD

N/A

Value

Gain YTD

-26.634

View a ticker or compare two or three

Compare

TVRD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for TVRD

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details